trachea and human bronchus. This derivative acts mainly by inhibiting cellular influx of extracellular calcium since it inhibits potently and dose-dependently the contractions of rat trachea to high concentrations of KCI and to CaCl2 in a depolarizing medium. It appears to act weakly by inducing cGMP and cAMP synthesis. Moreover, its relaxing activity is not related to an inhibition of phosphodiesterases
由相应的六氢a庚因-2,3-二酮制备了一系列新的Z和E 3- [O-(苄基取代的-
肟基醚)-六氢hydro庚因-2,3-二酮,并作为平滑肌松弛剂进行了测试。E和Z结构通过NMR分析确定,并通过使用同步加速器辐射的X射线衍射确定16(E和Z)。硝基苄基衍
生物16是体外最有效的用
乙酰胆碱预收缩的大鼠气管松弛剂。E异构体16b比Z异构体16a更有效。E异构体16b比
氨茶碱更有效
地松弛大鼠气管和人支气管。该衍
生物主要通过抑制细胞外
钙的流入而起作用,因为它在去极化介质中有效和剂量依赖性地抑制大鼠气管收缩至高浓度的KCI和
CaCl2。它似乎通过诱导cGMP和c
AMP合成而作用较弱。而且,其松弛活性与
磷酸二酯酶的抑制,
钾通道的开放或
前列腺素合成的诱导无关。因此,16b似乎主要作为有效的
钙拮抗剂起作用。